New study cautions transgender women and physicians to approach standard screening guidelines with caution. Hormone therapy in transgender women can...

Study finds that transgender women on hormone therapy may have early-stage prostate cancer missed by current PSA screening guidelines.

Current prostate cancer tests may fail to detect early-stage disease in transgender women, potentially leading to delayed diagnosis and treatment.

With NIH funding, a new study aims to better detect early-stage diseases such as cancer and dementia.

FRIDAY, June 21, 2024 -- The overall prevalence of up-to-date (UTD) lung cancer screening (LCS) was low in 2022, with prevalence increasing with age...

MONDAY, July 1, 2024 -- Current screening standards could miss early-stage prostate cancer in transgender women, a new study warns. Prostate cancer...

An artificial intelligence-powered method for detecting tumour DNA in blood has shown unprecedented sensitivity in predicting cancer recurrence, in a...

A research effort led by Dean Tang, PhD, of Roswell Park Comprehensive Cancer Center, USA, sheds light on a critical area of oncologic study — the...

Transgender women continue to face the risk of developing prostate cancer. A recent study conducted by Cedars-Sinai Cancer researchers, published in...

The 3D Urology and Prostate Clinics are revolutionizing prostate treatment with their 3D Natural Prostate Treatment and 3D Prostate Cancer Targeted...